DEPO-MEDROL

This brand name is authorized in Australia, Brazil, Canada, Ecuador, Estonia, Finland, France, Hong Kong, Croatia, Israel, Japan, Mexico, Netherlands, New Zealand, Poland, Tunisia, Turkey, United States

Active ingredients

The drug DEPO-MEDROL contains one active pharmaceutical ingredient (API):

1 Methylprednisolone UNII 43502P7F0P - METHYLPREDNISOLONE ACETATE

Methylprednisolone is a synthetic glucocorticoid and a methyl derivative of prednisolone. Methylprednisolone is a potent anti-inflammatory agent with the capacity to profoundly inhibit the immune system. Read about Methylprednisolone

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
DEPO-MEDROL Suspension for injection	Medicines and Medical Devices Safety Authority (NZ)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
H02AB04	Methylprednisolone	H Systemic hormonal preparations, excl. Sex hormones and insulins → H02 Corticosteroids for systemic use → H02A CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN → H02AB Glucocorticoids
Discover more medicines within H02AB04

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: AU	Pharmaceutical Benefits Scheme	Identifier(s): 1928L, 5148Y
Country: BR	Câmara de Regulação do Mercado de Medicamentos	Identifier(s): 522718040079917
Country: CA	Health Products and Food Branch	Identifier(s): 00030759, 00030767, 01934325, 01934333, 01934341
Country: EC	Agencia Nacional de Regulación, Control y Vigilancia Sanitaria	Identifier(s): 360560612
Country: EE	Ravimiamet	Identifier(s): 1009190, 1065495, 1065507, 1309597, 1309609
Country: FI	Lääkealan turvallisuus- ja kehittämiskeskus	Identifier(s): 189514, 189522
Country: FR	Base de données publique des médicaments	Identifier(s): 64085814
Country: HK	Department of Health Drug Office	Identifier(s): 00490
Country: HR	Agencija za lijekove i medicinske proizvode	Identifier(s): HR-H-890794207
Country: IL	מִשְׂרַד הַבְּרִיאוּת	Identifier(s): 35, 36, 37
Country: JP	医薬品医療機器総合機構	Identifier(s): 2456402C1044, 2456402C2040
Country: MX	Comisión Federal para la Protección contra Riesgos Sanitarios	Identifier(s): 55041
Country: NL	Z-Index G-Standaard	Identifier(s): 14040441, 14040468
Country: NL	Z-Index G-Standaard, PRK	Identifier(s): 2267, 4839
Country: NZ	Medicines and Medical Devices Safety Authority	Identifier(s): 1130
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100192605, 100352530, 100437082
Country: TN	Direction de la Pharmacie et du Médicament	Identifier(s): 8013051
Country: TR	İlaç ve Tıbbi Cihaz Kurumu	Identifier(s): 8681308771063
Country: US	FDA, National Drug Code	Identifier(s): 0009-0274, 0009-0280, 0009-0306, 0009-3073, 0009-3475, 50090-0312, 70518-0516, 70518-2148, 76420-081